Dr. Daisy Escobar , MD
Internal Medicine - Hematology & Oncology โข Mobile, AL
1660 Spring Hill Ave
Mobile, AL 366041405
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Daisy Escobar is listed in NPPES under Internal Medicine - Hematology & Oncology.
-
NPI assigned on July 25, 2018; this date does not establish years in practice.
-
Published CMS data list 57 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 โ Established patient outpatient office visit: 34 service units.
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 23 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See the full table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 137 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) โ 23 prescription fills, including refills.
- Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) โ 16 prescription fills, including refills.
- Tafinlar (Dabrafenib Mesylate) โ 15 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 10 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 90% of clinicians listed under Internal Medicine - Hematology & Oncology in Mobile, AL (2024, 21 clinicians with data). Median for this group: 1,041. Middle half: 175 to 35,831.
Fewer Medicare Part B services than 95% of clinicians listed under Internal Medicine - Hematology & Oncology in Alabama (2024, 137 clinicians with data). Median for this group: 1,057. Middle half: 368 to 45,835.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 68 in 2020 to 137 in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2020โ2024.
Practice Location & Contact Primary Location
1660 Spring Hill Ave
Mobile, AL 366041405
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Usa Health - Mci Business Services Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2009
What Public CMS Data Show
Internal Medicine - Hematology & Oncology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
28 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $4,309 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $3,434 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
137 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,077,059 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,694.73 across 124 records.
By nature of payment
- Food and Beverage: $2,694.73 across 124 records.
Reporting-company totals (3 largest of 37)
- Novartis Pharmaceuticals Corporation: $257.40 across 13 records.
- AstraZeneca Pharmaceuticals LP: $189.99 across 8 records.
- Regeneron Pharmaceuticals, Inc.: $189.24 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
17 years (graduated 2009)
CMS Doctors and Clinicians data list 2009 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2018
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Escobar has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Escobar as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Mobile and Alabama
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 90% of clinicians listed under Internal Medicine - Hematology & Oncology in Mobile, AL (2024, 21 clinicians with data). Median for this group: 1,041. Middle half: 175 to 35,831.
Fewer Medicare Part B services than 95% of clinicians listed under Internal Medicine - Hematology & Oncology in Alabama (2024, 137 clinicians with data). Median for this group: 1,057. Middle half: 368 to 45,835.
Medicare-allowed amount
A lower Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Hematology & Oncology in Mobile, AL (2024, 21 clinicians with data). Median for this group: $83,273. Middle half: $13,744 to $1,053,455.
A lower Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Hematology & Oncology in Alabama (2024, 137 clinicians with data). Median for this group: $80,605. Middle half: $31,218 to $1,187,429.
Paid by Medicare
A lower Medicare payment amount than 90% of clinicians listed under Internal Medicine - Hematology & Oncology in Mobile, AL (2024, 21 clinicians with data). Median for this group: $61,236. Middle half: $10,680 to $838,322.
A lower Medicare payment amount than 95% of clinicians listed under Internal Medicine - Hematology & Oncology in Alabama (2024, 137 clinicians with data). Median for this group: $61,236. Middle half: $23,856 to $957,553.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Internal Medicine - Hematology & Oncology in Mobile, AL (2024, 24 clinicians with data). Median for this group: 594. Middle half: 120 to 1,577.
Fewer Part D prescriptions than 85% of clinicians listed under Internal Medicine - Hematology & Oncology in Alabama (2024, 138 clinicians with data). Median for this group: 1,079. Middle half: 355 to 1,889.
Part D drug cost
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Mobile, AL (2024, 24 clinicians with data). Median for this group: $828,582. Middle half: $20,501 to $3,729,850.
A lower Part D drug cost than 65% of clinicians listed under Internal Medicine - Hematology & Oncology in Alabama (2024, 138 clinicians with data). Median for this group: $2,734,930. Middle half: $329,246 to $4,321,788.
28 active clinicians are listed under Internal Medicine - Hematology & Oncology with a practice address in Mobile, AL (191 in Alabama).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Mobile
10.7% of these 28 clinicians have the CMS telehealth indicator.
82.1% of these 28 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
CMS data for Medicare Part B services are available for 2024 only.
-
Medicare-allowed amount
CMS data for Medicare-allowed amount are available for 2024 only.
-
Paid by Medicare
CMS data for Medicare payment amount are available for 2024 only.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 101% from 68 in 2020 to 137 in 2024.
- 2020: 68
- 2021: 58
- 2022: 34
- 2023: 83
- 2024: 137
-
30-day fills
30-day fills varied from year to year: 126 in 2020 and 137 in 2024.
- 2020: 126
- 2021: 106
- 2022: 36
- 2023: 83
- 2024: 137
-
Part D drug cost
Part D drug cost went from $494 in 2020 to $1,077,059 in 2024.
- 2020: $494
- 2021: $508
- 2022: $591
- 2023: $332,766
- 2024: $1,077,059
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $343.00 in 2021 to $2,694.73 in 2025.
- 2021: $343.00
- 2022: $2,336.38
- 2023: $3,495.16
- 2024: $2,468.50
- 2025: $2,694.73
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 124 records totaling $2,694.73.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| SERVIER PHARMACEUTICALS LLC |
Food and Beverage
In-kind items and services
|
Voranigo | General | $125.00 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $118.94 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
โ | General | $111.99 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TAGRISSO | General | $79.07 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $73.38 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XYNTHA | General | $37.52 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VENCLEXTA | General | $34.67 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
VERZENIO | General | $30.54 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
MONJUVI | General | $29.95 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
MONJUVI | General | $29.95 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
REBLOZYL | General | $29.45 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
Enhertu | General | $27.76 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
IMBRUVICA | General | $27.75 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
REBLOZYL | General | $27.60 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
EPKINLY | General | $27.46 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
TIVDAK | General | $26.69 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
DATROWAY | General | $26.63 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
INJECTAFER | General | $25.40 |
| Exelixis Inc. |
Food and Beverage
In-kind items and services
|
CABOMETYX | General | $25.19 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
DATROWAY | General | $24.84 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
REBLOZYL | General | $24.31 |
| TerSera Therapeutics LLC |
Food and Beverage
In-kind items and services
|
Quzyttir | General | $24.29 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
Enhertu | General | $24.22 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $24.05 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VENCLEXTA | General | $23.84 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
34 | 19 | $257.00 | $116.48 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
23 | 16 | $46.00 | $15.17 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 23 | 630 | $547.02 | โ |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | 341 | $463.29 | โ |
| Tafinlar | Dabrafenib Mesylate | 15 | 450 | $197,386.49 | โ |
| Mekinist | Trametinib Dimethyl Sulfoxide | 14 | 420 | $200,656.40 | โ |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | 180 | $86.66 | โ |
| Ibrance | Palbociclib | 12 | 336 | $180,281.40 | โ |
| Brukinsa | Zanubrutinib | 12 | 360 | $180,143.03 | โ |
| Acyclovir | Acyclovir | 11 | 330 | $22.31 | โ |
| Jakafi | Ruxolitinib Phosphate | 11 | 330 | $167,399.24 | โ |
| Nubeqa | Darolutamide | 11 | 330 | $150,073.22 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-06-24NUCC Taxonomy Code: 207RH0003X
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
NUCC Taxonomy Code: 207RX0202X
An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 390200000X
An individual who is enrolled in an organized health care education/training program leading to a degree, certification, registration, and/or licensure to provide health care.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - HEMATOLOGY/ONCOLOGY
I20240815000617
AL
6002168168
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Usa Health - Mci Business Services Llc
1047 Fairhope Ave, Fairhope, AL 365323145
Phone: 2519901850
Usa Health - Mci Business Services Llc
1660 Spring Hill Ave, Mobile, AL 366041405
Phone: 2516658000
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Nurse Practitioner
Certified Registered Nurse Practitioner
Nurse Practitioner - Family
Certified Registered Nurse Practitioner
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Certified Registered Nurse Practitioner
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at PO BOX 40098, MOBILE, AL 366400098 (Tel: 2514343473)
Internal Medicine (license number reported to NPPES: AL L4849R)
Registered at 1660 SPRING HILL AVE, MOBILE, AL 366041405 (Tel: 2514459895)
Registered at 1660 SPRING HILL AVE, MOBILE, AL 366041405 (Tel: 2514459895)
Internal Medicine (license number reported to NPPES: AL L4849R)
NPI status registered as active in NPPES database
Registered at 2451 USA MEDICAL CENTER DR RM 714, MOBILE, AL 366172300 (Tel: 2514717117)
Registered at 2451 USA MEDICAL CENTER DR RM 714, MOBILE, AL 366172300 (Tel: 2514717117)
Recorded as DAISY ESCOBAR, MD
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Hematology & Oncology Specialists in Mobile
- Dr. Ahmed Abdalla, MD
- Dr. Connie Uzel, MD
- Dr. Jeffrey George, MD
- Dr. Carmel Verrier, MD
- Dr. Nabin Karki, MD
- Dr. Prajwol Pathak, MD
Mailing Address
Po Box 40098
Mobile, AL 366400098
Phone: 2514343473